Erectile Dysfunction in the Hypogonadal Male: Rethinking Physiology, Pharmacology, and the Path to Restored Sexual Function

Erectile dysfunction (ED) in men with hypogonadism represents a particularly intricate clinical scenario—one in which endocrine insufficiency intersects with vascular impairment, psychological burden, and pharmacological resistance. Although phosphodiesterase-5 (PDE5) inhibitors such as sildenafil revolutionized ED management more than two decades…

A Comprehensive Medical Review of the Aphrodisiac Potential of Monsonia angustifolia: Insights from In-Vivo Studies in Male Wistar Rats

The search for safe, effective, and reliable aphrodisiac agents remains an ongoing priority in both modern pharmacotherapy and traditional medical systems. While pharmaceuticals such as sildenafil citrate have indisputably revolutionized the management of erectile dysfunction, the parallel growth of interest…

Clinical Pharmacology and Comparative Efficacy of Tramadol, Sildenafil, Paroxetine, and Topical Anaesthetics in the On-Demand Treatment of Premature Ejaculation

Introduction Premature ejaculation (PE) remains one of the most prevalent male sexual disorders, affecting up to 30% of sexually active men worldwide. Despite its frequency, it continues to challenge clinicians due to the interplay between psychological, neurobiological, and pharmacological determinants….